GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide, and dulaglutide — have become the most-prescribed weight loss medications in modern history. Millions of men are taking them. And there's a narrative circulating online that GLP-1s "destroy testosterone" or "tank your hormones." That's not what the research actually shows. The honest picture is more complicated — and the real concern is one that almost no one is talking about.
This article walks through what the actual research says about GLP-1s and testosterone, why the "destroys testosterone" narrative gets it wrong, and the real long-term concern men on GLP-1s should be tracking: the lean mass loss that quietly erodes the muscle-testosterone feedback loop over time.
What the Research Actually Shows: GLP-1s Often RAISE Testosterone
The data on GLP-1s and testosterone is consistent and the opposite of what the alarmist narrative claims. Multiple systematic reviews and clinical studies show that GLP-1 receptor agonists are associated with increased testosterone levels in men, particularly in men with obesity, type 2 diabetes, or functional hypogonadism.
A 2025 systematic review published in PubMed analyzed 10 studies involving 639 men taking GLP-1RAs (liraglutide, semaglutide, dulaglutide, and exenatide). The review concluded that GLP-1RAs were consistently associated with increased total testosterone, particularly in men with obesity, type 2 diabetes, or functional hypogonadism.
A 2025 study of 110 men with obesity and type 2 diabetes showed a 10% weight reduction and a 53% to 77% increase in testosterone levels over 18 months on GLP-1 medications including semaglutide, dulaglutide, and tirzepatide. A separate 2025 ICS-EUS systematic review of seven studies and 371 participants concluded that GLP-1RA therapy was associated with significant increases in total testosterone concentrations, particularly among obese men and individuals with metabolic dysfunction.
The mechanism is straightforward. In obese men, body fat converts testosterone to estrogen via aromatase. Reducing body fat reduces aromatase activity. Improved insulin sensitivity also supports testicular function. GLP-1s, by driving weight loss and improving metabolic control, indirectly restore testosterone in men whose hormones were suppressed by the metabolic dysfunction in the first place.
This is why the "GLP-1s destroy testosterone" narrative is wrong. For most men taking these drugs, testosterone goes up, not down.
So What's the Real Concern?
The actual problem with GLP-1s in terms of male hormonal health isn't direct testosterone suppression. It's lean mass loss — and over time, that lean mass loss creates a downstream hormonal problem.
Multiple clinical studies have documented that up to 25–39% of the weight lost on GLP-1 medications comes from lean body mass — including skeletal muscle. A 2025 review in ScienceDirect notes that GLP-1 RAs may induce up to 25% of fat-free mass loss. Other research, including industry analyses, has cited figures closer to 39% lean mass loss in some patient populations.
This matters because lean muscle mass is metabolically active tissue that:
- Supports testosterone production indirectly through the muscle-testosterone feedback loop
- Drives basal metabolic rate — losing muscle means burning fewer calories at rest
- Improves insulin sensitivity — which protects testosterone over time
- Maintains bone density — protecting against secondary osteoporosis (a known consequence of low testosterone)
- Preserves functional strength — critical for healthy aging and quality of life
When a man loses 25–40% of his total weight loss as muscle, he's eroding the metabolic and hormonal foundation that maintains his testosterone over the long term. The short-term testosterone increase from fat loss may not be sustained if the underlying muscle base keeps shrinking.
The GLP-1 + Sarcopenia Connection
Sarcopenia — the progressive loss of muscle mass and strength — is a well-documented driver of declining testosterone in aging men. Testosterone and muscle mass exist in a bidirectional relationship: testosterone supports muscle growth, and muscle mass supports healthy testosterone production. Lose one, and you lose the other.
A 2022 review in PMC examining testosterone and sarcopenia in older men noted that testosterone is essential for maintaining skeletal muscle mass and strength, and testosterone deficiency is significantly associated with sarcopenia onset. Multiple randomized controlled studies support the beneficial effect of testosterone replacement on muscle volume and strength in men with low-to-normal testosterone.
When GLP-1s drive rapid weight loss with significant lean mass loss, particularly in men who aren't simultaneously strength training, the long-term result is potentially:
- Reduced muscle mass
- Sarcopenic obesity (less muscle, regained fat after stopping the drug)
- Impaired metabolic health
- Eroded testosterone substrate
The short-term hormonal benefits from fat loss can be eclipsed by the long-term consequences of muscle loss if the lean mass isn't actively preserved.
The Weight Regain Problem Makes It Worse
Most men don't stay on GLP-1s indefinitely. The drugs are expensive, side effects accumulate, and many discontinue after reaching weight loss goals. The problem: a meta-analysis of eight randomized controlled trials reported that participants taking semaglutide or tirzepatide regained 9.69 kg (95% CI 5.78–13.60) over 48–52 weeks after stopping the medication.
The regained weight tends to be disproportionately fat, not muscle. Body composition research shows that fat is typically regained faster than lean mass after weight loss. The cycle:
- Man starts GLP-1, loses 50 lbs (15 lbs of which is muscle)
- Testosterone goes up due to fat loss and improved metabolic markers
- Man stops the drug
- Regains 30 lbs over the next year, mostly as fat
- Now has less muscle AND more fat than before he started
- Testosterone drops back down, possibly lower than baseline
This is the sarcopenic obesity trap — a worse hormonal and metabolic position than the starting point. Men who use GLP-1s without an aggressive muscle preservation strategy are at real risk of ending up worse off than they started.
The Honest Concern Beyond the Hype
There's also some emerging signal worth tracking. A retrospective cohort study using the TriNetX Research database examined erectile dysfunction incidence in 3,094 non-diabetic men with obesity (aged 18–50) prescribed semaglutide for weight management. The semaglutide group showed a higher incidence of newly diagnosed ED (1.47% vs 0.32%) and testosterone deficiency (1.53% vs 0.80%) compared with matched controls.
These are small absolute numbers, and confounders exist, but the signal suggests that in some subgroups — particularly non-diabetic men with obesity using semaglutide — there may be adverse sexual or hormonal effects. The evidence is mixed enough that men using these drugs should track their symptoms and bloodwork, not assume they're hormonally protected.
How to Protect Testosterone If You're Using a GLP-1
Men taking GLP-1 medications should treat lean mass preservation as the central problem, not a side issue. The protocol:
- Strength train consistently. Heavy resistance training (compound lifts, 3–5x/week) is the single most powerful lever for muscle preservation during weight loss.
- Eat enough protein. Most clinical guidelines recommend 1.2–1.6 grams of protein per kilogram of bodyweight during active weight loss, possibly higher in older men. GLP-1s suppress appetite — you have to be intentional about hitting protein.
- Avoid extreme caloric deficits. A modest deficit (500 calories/day) is sufficient for steady weight loss. Bigger deficits accelerate muscle loss without proportional fat loss benefit.
- Get comprehensive testosterone bloodwork. Total T, free T, SHBG, LH, FSH, estradiol — at baseline, at 3 months, at 6 months. Track the trajectory.
- Track symptoms. Energy, libido, morning erections, gym performance, cognitive function. If any decline meaningfully, investigate.
- Consider hormonal and cognitive support. Compounds that support testosterone production and the muscle-hormonal axis (ashwagandha, vitamin D, zinc, magnesium) help preserve the system while you're losing weight.
After GLP-1: The Reload Problem
If you stop or plan to stop a GLP-1, the protocol for protecting hormones during the transition:
- Continue strength training aggressively. This is when muscle preservation matters most.
- Maintain protein intake. Don't drop protein just because appetite returns.
- Plan for slow caloric reintroduction. Don't immediately return to pre-GLP-1 eating patterns.
- Track weight composition, not just weight. A DXA scan or body fat measurement is more useful than the scale.
- Address hormonal foundation. This is when testosterone-supporting interventions matter most because the weight regain pattern can push hormones in the wrong direction.
The Integrated Approach
The men who use GLP-1s most successfully don't treat them as standalone tools. They use them as one input in a broader hormonal and metabolic strategy. That means:
- GLP-1s for fat loss and metabolic improvement
- Strength training for muscle preservation
- Adequate protein for muscle protein synthesis
- Sleep and stress management for hormonal recovery
- Targeted supplementation for the testosterone-muscle-cognition axis
This is the framework behind Testostemem — built around the integrated system that governs male hormones, metabolism, and performance. The product combines clinically dosed ashwagandha (which supports testosterone, lowers cortisol, and has evidence for supporting muscle gains in trained men) with other compounds that protect the hormonal substrate during weight loss interventions. For men using GLP-1s or considering them, addressing the broader system is what protects long-term outcomes.
Frequently Asked Questions About GLP-1s and Testosterone
Do GLP-1s lower testosterone?
The research is the opposite — GLP-1s are consistently associated with increased testosterone in obese and diabetic men, primarily because fat loss reduces aromatase activity. The real concern isn't direct testosterone suppression — it's the lean mass loss that erodes the muscle-testosterone feedback loop over time.
How much muscle do you lose on GLP-1s?
Research suggests 25–39% of total weight lost on GLP-1 medications comes from lean body mass, including skeletal muscle. The proportion can be higher in men who aren't strength training during the medication.
Can GLP-1s cause sexual side effects?
Most data shows neutral or positive effects on male sexual function. However, a retrospective cohort study found higher rates of new-onset ED and testosterone deficiency in non-diabetic men with obesity using semaglutide. Track symptoms and bloodwork if you're in this population.
How do I preserve muscle while on a GLP-1?
Heavy strength training (3–5 sessions per week), adequate protein intake (1.2–1.6 g/kg bodyweight or higher), moderate caloric deficits rather than aggressive ones, and tracking body composition (not just weight) are the core protocol.
What happens to testosterone when you stop a GLP-1?
The weight regain that typically follows GLP-1 discontinuation tends to be disproportionately fat, not muscle. This can push men into sarcopenic obesity — less muscle and more fat than before — which is a worse hormonal position than the starting point. Active muscle preservation during and after the medication is critical.